Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A for Restless Legs Syndrome
NCT00479154Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- May 2007
- Primary completion
- Apr 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in restless legs syndrome (RLS), sponsored by National Institute of Neurological Disorders and Stroke. Started May 2007; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00479154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00479154.